Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis.

[1]  P. Vickerman,et al.  Assessing the cost‐effectiveness of finding cases of hepatitis C infection in UK migrant populations and the value of further research , 2014, Journal of viral hepatitis.

[2]  R. Anders,et al.  P94 Retrospective study to assess the background incidence of Hepatitis B and C in patients with Tuberculosis and latent tuberculosis at Whipps Cross Hospital , 2013, Thorax.

[3]  J. Ward,et al.  Expanded Hepatitis C Virus Screening Recommendations Promote Opportunities for Care and Cure , 2013, Annals of Internal Medicine.

[4]  F. Blasi,et al.  Indicator condition-guided HIV testing in Europe: a step forward to HIV control , 2013, European Respiratory Journal.

[5]  V. Moyer,et al.  Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement , 2013, Annals of Internal Medicine.

[6]  Anne M Johnson,et al.  The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Wood,et al.  Differences in hepatitis B infection rate between ethnic groups in antenatal women in Birmingham, United Kingdom, May 2004 to December 2008. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  C. Beckwith,et al.  Experiences in implementation of routine human immunodeficiency virus testing in a US tuberculosis clinic. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  L. Rodrigues,et al.  Universal HIV testing in London tuberculosis clinics: a cluster randomised controlled trial , 2012, European Respiratory Journal.

[10]  A. Lok,et al.  Effectiveness of hepatitis B treatment in clinical practice. , 2012, Gastroenterology.

[11]  C. Leen,et al.  UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients , 2012, Alimentary pharmacology & therapeutics.

[12]  H. Thomas,et al.  Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin , 2010, Journal of viral hepatitis.

[13]  R. D. de Man,et al.  Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. , 2010, Gastroenterology.

[14]  T. Sterling,et al.  American Thoracic Society Documents An Official ATS Statement : Hepatotoxicity of Antituberculosis Therapy , 2006 .

[15]  Douglas K Owens,et al.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. , 2005, The New England journal of medicine.

[16]  M. Lipman,et al.  HIV pre-test discussion , 1996, BMJ.

[17]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[18]  Bibliographic Sources.  Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement , 2013, Annals of Internal Medicine.

[19]  Hiv.  UK national guidelines for HIV testing. , 2008 .